Broadview Ventures adds two to strategic advisory board


loscalzoBoston-based venture capital firm Broadview Ventures has strengthened its strategic advisory board with the appointments of Joseph Loscalzo and Argeris Karabelas.

Loscalzo, pictured, is the Hersey professor of the theory and practice of medicine at Harvard Medical School, chairman of the Department of Medicine, physician-in-chief at Brigham and Women’s Hospital.

He has previously served on the advisory council of the National Heart, Lung, and Blood Institute and the council of councils of the National Institutes of Health.

Karabelas is a partner at New jersey-based life sciences venture capital firm Care Capital and the founder of the Novartis BioVenture Fund.

Previous to that he worked as CEO of the Novartis healthcare division and executive vice-president and head of global pharmaceuticals at SmithKline Beecham.

Broadview managing director Christopher Colecchi said, “We are excited to add Dr. Loscalzo and Dr.Karabelas to our strategic advisory board.

“Their combined experience adds breadth and depth across the areas of drug development, venture capital, research, and clinical care.”

Broadview is focused on investing in early stage businesses focused on developing technology in cardiovascular and neurovascular diseases.

Copyright © 2013 AltAssets